chr1	100206504	100206504	T	C	exonic	DBT		nonsynonymous SNV	DBT:NM_001918:exon9:c.A1150G:p.S384G	rs12021720	Pathogenic,other	Intermediate_maple_syrup_urine_disease_type_2,not_specified	RCV000012727.23,RCV000116865.5	MedGen,MedGen	CN069615,CN169374	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.629	N	1	0.090	P	.	.	.	1.19	0.376	T	3.03	0.001	N	0.155	0.185	-1.012	0.262	T	0.014	0.055	T	.	.	.	-0.197	0.076	1.112	0.151	0.004	0.017	0.052	N	c	-0.706	-0.588	0.043	0.146	0.707	0.730	0	4.4	0.522	1.939	0.396	0.069	0.176	0.586	0.274	0.510	0.273	9.627	0.387	2-oxoacid dehydrogenase acyltransferase, catalytic domain|Chloramphenicol acetyltransferase-like domain	ENSG00000137996.8|ENSG00000137996.8|ENSG00000137992.10|ENSG00000137996.8|ENSG00000137992.10|ENSG00000137996.8|ENSG00000137996.8|ENSG00000117620.8|ENSG00000137996.8|ENSG00000137992.10|ENSG00000137996.8|ENSG00000137996.8|ENSG00000137996.8|ENSG00000137996.8|ENSG00000137996.8|ENSG00000137992.10|ENSG00000137996.8|ENSG00000137996.8|ENSG00000137996.8	Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Esophagus_Gastroesophageal_Junction|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Testis|Thyroid
chr3	38603929	38603929	T	C	exonic	SCN5A		nonsynonymous SNV	SCN5A:NM_000335:exon12:c.A1673G:p.H558R,SCN5A:NM_001099404:exon12:c.A1673G:p.H558R,SCN5A:NM_001099405:exon12:c.A1673G:p.H558R,SCN5A:NM_001160160:exon12:c.A1673G:p.H558R,SCN5A:NM_001160161:exon12:c.A1673G:p.H558R,SCN5A:NM_198056:exon12:c.A1673G:p.H558R	rs1805124	Pathogenic|Benign|not provided|Benign|Likely benign|Likely benign|Likely benign|Likely benign|Likely benign|Likely benign|Likely benign	Progressive_familial_heart_block_type_1A|not_specified|not_provided|Cardiovascular_phenotype|Long_QT_syndrome|Sick_sinus_syndrome|Brugada_syndrome|Romano-Ward_syndrome|Dilated_Cardiomyopathy,_Dominant|Paroxysmal_familial_ventricular_fibrillation|Progressive_familial_heart_block	RCV000010000.3|RCV000041604.5|RCV000058440.3|RCV000251327.1|RCV000300603.1|RCV000304709.1|RCV000335618.1|RCV000339196.1|RCV000361696.1|RCV000405409.1|RCV000406777.1	MedGen:OMIM|MedGen|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet	C1879286:113900|CN169374|CN221809|CN230736|D008133:C0023976:9651007|C0037052:ORPHA166282:36083008|C1142166:ORPHA130:418818005|CN119492:20852007|CN239310|C0340493:ORPHA228140:233915000|CN206278:ORPHA871	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.009	0.304	N	0.998	0.225	P	-2.58	0.000	N	-3.39	0.945	D	3.92	0.001	N	0.091	0.349	-0.924	0.450	T	0.000	0.000	T	.	.	.	-1.102	0.028	0.010	0.286	0.015	0.024	0.068	N	c	-1.528	-1.240	0.998	0.368	0.615	0.372	0	2.44	0.287	1.276	0.325	-1.897	0.006	0.956	0.331	0.751	0.322	15.575	0.760	Voltage-gated Na+ ion channel, cytoplasmic domain	.	.
chr5	35871088	35871088	G	A	exonic	IL7R		nonsynonymous SNV	IL7R:NM_002185:exon4:c.G412A:p.V138I	rs1494555	Pathogenic|Benign|Benign	Severe_combined_immunodeficiency,_autosomal_recessive,_T_cell-negative,_B_cell-positive,_NK_cell-positive|not_specified|Severe_Combined_Immune_Deficiency	RCV000015965.26|RCV000121214.2|RCV000397982.1	MedGen:OMIM|MedGen|MedGen	C1837028:608971|CN169374|CN239264	0.664	0.046	T	0.0	0.026	B	0.0	0.013	B	0.488	0.121	N	1	0.090	P	.	.	.	-1.12	0.776	T	-0.77	0.214	N	0.059	0.043	-0.974	0.363	T	0.000	0.000	T	.	.	.	-0.630	0.048	0.106	0.283	0.014	0.003	0.015	N	c	-1.365	-1.402	0.956	0.282	0.615	0.372	0	-1.61	0.079	0.106	0.151	-1.534	0.010	0.000	0.063	0.008	0.104	11.700	0.506	Fibronectin type III|Immunoglobulin-like fold	ENSG00000168685.10	Testis
chr5	74685445	74685445	T	C	exonic	HEXB		nonsynonymous SNV	HEXB:NM_000521:exon1:c.T185C:p.L62S	rs820878	Pathogenic,Benign	Sandhoff_disease,_infantile_type,not_specified	RCV000004086.3,RCV000153357.2	MedGen,MedGen	C1849322,CN169374	1.0	0.010	T	.	.	.	.	.	.	0.013	0.290	N	1	0.211	P	.	.	.	-0.42	0.695	T	2.73	0.002	N	0.063	0.234	-0.909	0.469	T	0.000	0.000	T	.	.	.	-0.640	0.048	0.100	0.703	0.090	0.000	0.004	N	c	-0.764	-0.847	1.000	0.747	0.733	0.969	0	3.99	0.454	0.769	0.261	-0.093	0.117	0.001	0.137	0.006	0.095	8.757	0.336	Beta-hexosaminidase, eukaryotic type, N-terminal|Chitobiase/beta-hexosaminidase domain 2-like	.	.
chr7	150999023	150999023	T	G	exonic	NOS3		nonsynonymous SNV	NOS3:NM_001160109:exon7:c.T894G:p.D298E,NOS3:NM_001160110:exon7:c.T894G:p.D298E,NOS3:NM_001160111:exon7:c.T894G:p.D298E,NOS3:NM_000603:exon8:c.T894G:p.D298E	rs1799983	other|other|other|Pathogenic|other|other|Benign	Coronary_artery_spasm_1,_susceptibility_to|Alzheimer_disease,_late-onset,_susceptibility_to|Hypertension,_pregnancy-induced,_susceptibility_to|Hypertension_resistant_to_conventional_therapy|Ischemic_heart_disease,_susceptibility_to|Ischemic_stroke,_susceptibility_to|not_specified	RCV000015053.3|RCV000015054.3|RCV000015055.3|RCV000015056.26|RCV000015057.3|RCV000015058.3|RCV000455688.1	MedGen	CN169374	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.001	0.425	N	1.000	0.191	P	.	.	.	2.12	0.197	T	0.9	0.019	N	0.045	0.032	-0.957	0.397	T	0.000	0.000	T	.	.	.	-0.419	0.060	0.348	0.216	0.008	0.095	0.150	N	c	-0.952	-0.884	1.000	0.411	0.707	0.730	0	1.04	0.191	-0.502	0.064	-0.347	0.071	0.015	0.189	0.954	0.431	0.711	0.009	Nitric oxide synthase, N-terminal	.	.
chr10	68885620	68885620	A	C	exonic	STOX1		nonsynonymous SNV	STOX1:NM_001130161:exon3:c.A1824C:p.E608D,STOX1:NM_152709:exon3:c.A1824C:p.E608D	rs10509305	Pathogenic	Preeclampsia/eclampsia_4	RCV000001790.2	MedGen:OMIM	C1836255:609404	0.983	0.020	T	0.0	0.026	B	0.0	0.013	B	0.862	0.071	N	1	0.090	P	-1.63	0.004	N	-0.81	0.740	T	0.96	0.015	N	0.03	0.011	-1.085	0.065	T	0.000	0.000	T	.	.	.	-3.111	0.001	0.001	0.090	0.001	0.051	0.108	N	c	-1.970	-1.809	0.000	0.012	0.615	0.372	0	1.14	0.197	-1.561	0.022	-1.391	0.012	0.000	0.063	0.000	0.016	0.041	0.000	.	ENSG00000165730.10|ENSG00000165730.10|ENSG00000198954.4|ENSG00000165730.10|ENSG00000165730.10	Adrenal_Gland|Lung|Muscle_Skeletal|Muscle_Skeletal|Whole_Blood
chr11	66560624	66560624	C	T	exonic	ACTN3		stopgain	ACTN3:NM_001104:exon15:c.C1729T:p.R577X,ACTN3:NM_001258371:exon15:c.C1858T:p.R620X	rs1815739	Benign|Pathogenic|other	ACTININ,_ALPHA-3_POLYMORPHISM|ACTN3_deficiency|Sprinting_performance	RCV000019974.2|RCV000019975.27|RCV000019976.27	MedGen|MedGen	CN071807|C2319308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.945	0.276	0.257	0.036	0	4.66	0.577	1.339	0.333	0.935	0.490	0.997	0.399	0.998	0.697	5.976	0.185	.	.	.
chr12	54283860	54283860	A	G	exonic	HNRNPA1		nonsynonymous SNV	HNRNPA1:NM_002136:exon8:c.A800G:p.N267S,HNRNPA1:NM_031157:exon9:c.A956G:p.N319S	rs397518454	Pathogenic	Amyotrophic_lateral_sclerosis_20	RCV000055651.22	MedGen:OMIM	C3715156:615426	0.22	0.912	T	0.451	0.342	B	0.091	0.284	B	0.000	0.477	D	0.680	0.332	D	1.195	0.303	L	-2.4	0.885	D	-1.9	0.511	N	0.059	0.203	-0.538	0.673	T	0.462	0.792	T	0.150	0.833	D	2.164	0.321	17.27	0.987	0.448	0.901	0.508	D	c	-0.200	-0.096	1.000	0.747	0.628	0.401	0	2.87	0.324	1.934	0.396	1.193	0.911	0.912	0.315	1.000	0.888	8.278	0.309	.	.	.
chr12	120999579	120999579	A	G	exonic	HNF1A		nonsynonymous SNV	HNF1A:NM_000545:exon9:c.A1720G:p.S574G,HNF1A:NM_001306179:exon9:c.A1741G:p.S581G	rs1169305	Pathogenic|Benign,not provided|Benign	Maturity-onset_diabetes_of_the_young,_type_3|not_specified,Maturity-onset_diabetes_of_the_young,_type_3|not_specified	RCV000016077.25|RCV000438436.1,RCV000030490.2|RCV000121200.1	MedGen:OMIM|MedGen,MedGen:OMIM|MedGen	C1838100:600496|CN169374,C1838100:600496|CN169374	0.779	0.033	T	0.0	0.026	B	0.0	0.013	B	0.043	0.238	N	1	0.090	P	.	.	.	-2.86	0.914	D	-0.08	0.082	N	0.266	0.323	-0.950	0.410	T	0.000	0.000	T	.	.	.	0.272	0.120	5.414	0.716	0.094	0.010	0.038	N	c	-0.944	-0.899	1.000	0.517	0.428	0.059	0	2.58	0.299	0.738	0.256	-0.200	0.102	0.478	0.266	0.047	0.162	8.164	0.302	Hepatocyte nuclear factor 1, alpha isoform C-terminal	.	.
chr12	121857429	121857429	T	C	exonic	HPD		nonsynonymous SNV	HPD:NM_002150:exon4:c.A97G:p.T33A	rs1154510	Pathogenic	4-Alpha-hydroxyphenylpyruvate_hydroxylase_deficiency	RCV000001643.2	MedGen:OMIM:Orphanet	C2931042:140350:ORPHA2118	1.0	0.010	T	.	.	.	.	.	.	0.000	0.843	N	0.997	0.810	P	.	.	.	-0.38	0.690	T	3.78	0.001	N	0.05	0.407	-0.945	0.418	T	0.000	0.000	T	.	.	.	-0.218	0.075	1.004	0.750	0.105	0.065	0.124	N	c	-0.224	-0.169	1.000	0.747	0.428	0.059	0	5.48	0.806	4.228	0.582	0.069	0.176	0.999	0.424	0.003	0.074	12.867	0.572	Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase|Glyoxalase/fosfomycin resistance/dioxygenase domain	ENSG00000158023.5|ENSG00000158023.5|ENSG00000158023.5|ENSG00000158023.5|ENSG00000158023.5	Artery_Tibial|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Testis
chr16	30086309	30086309	C	T	exonic	TBX6		synonymous SNV	TBX6:NM_004608:exon9:c.G1227A:p.P409P	rs2289292	Pathogenic|Benign	Spondylocostal_dysostosis_5|not_specified	RCV000167863.3|RCV000242581.2	MedGen:OMIM|MedGen	C1852521:122600|CN169374																																																																		
chr16	56514589	56514589	C	T	exonic	BBS2		nonsynonymous SNV	BBS2:NM_031885:exon2:c.G209A:p.S70N	rs4784677	Pathogenic,Benign	Bardet-biedl_syndrome_2/6,_digenic,not_specified	RCV000004838.4,RCV000301991.1	MedGen,MedGen	C4016908,CN169374	1.0	0.010	T	.	.	.	.	.	.	0.000	0.843	N	1.000	0.207	P	.	.	.	-1.16	0.781	T	2.81	0.002	N	0.048	0.203	-0.909	0.470	T	0.000	0.000	T	.	.	.	1.358	0.227	12.57	0.309	0.017	0.165	0.192	N	c	-0.085	0.026	1.000	0.747	0.706	0.609	0	5.54	0.828	4.993	0.634	0.119	0.209	1.000	0.715	1.000	0.888	10.250	0.424	Ciliary BBSome complex subunit 2, N-terminal|WD40-repeat-containing domain	.	.
chr16	69711242	69711242	G	A	exonic	NQO1		nonsynonymous SNV	NQO1:NM_001286137:exon4:c.C343T:p.P115S,NQO1:NM_001025433:exon5:c.C457T:p.P153S,NQO1:NM_001025434:exon5:c.C445T:p.P149S,NQO1:NM_000903:exon6:c.C559T:p.P187S	rs1800566	other|other|Pathogenic|drug response|not provided	Benzene_toxicity,_susceptibility_to|Leukemia,_post-chemotherapy,_susceptibility_to|Breast_cancer,_post-chemotherapy_poor_survival_in|Alkylating_Agents,_anthracyclines_and_related_substances,_fluorouracil,_and_Platinum_compounds_response_-_Efficacy|Lung_cancer	RCV000018300.2|RCV000018301.2|RCV000018302.23|RCV000211294.1|RCV000434090.1	MedGen|MedGen|MedGen|MedGen|MedGen:OMIM:SNOMED_CT	C2675718|C2675719|C2675722|CN236460|C0684249:211980:187875007	0.054	0.586	T	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.000	0.588	P	1.66	0.426	L	3.11	0.097	T	-7.53	0.951	D	0.853	0.859	-0.903	0.477	T	0.000	0.000	T	.	.	.	6.611	0.908	32	0.997	0.799	0.969	0.713	D	c	0.645	0.699	1.0	0.983	0.706	0.609	0	5.41	0.782	9.295	0.952	1.048	0.713	1.000	0.715	1.000	0.888	18.331	0.902	Flavodoxin-like fold|Flavoprotein-like domain;Flavoprotein-like domain	ENSG00000196696.8|ENSG00000196696.8|ENSG00000157335.15|ENSG00000196696.8|ENSG00000196696.8	Adipose_Subcutaneous|Esophagus_Mucosa|Lung|Skin_Sun_Exposed_Lower_leg|Testis
chr18	57571588	57571588	A	G	intronic	FECH				rs2272783	Pathogenic|Uncertain significance|Uncertain significance	Erythropoietic_protoporphyria|Erythema|Jaundice	RCV000000592.3|RCV000414979.1|RCV000414979.1	MedGen:OMIM:Orphanet:SNOMED_CT|Human_Phenotype_Ontology:MedGen|Human_Phenotype_Ontology:MedGen	C0162568:177000:ORPHA79278:51022005|HP:0010783:C0041834|HP:0000952:C0022346																																																																		
chr18	57580222	57580222	G	A	intronic	FECH				rs2269219	Pathogenic|Likely benign|Likely benign	Erythropoietic_protoporphyria|Erythema|Jaundice	RCV000000580.3|RCV000415389.1|RCV000415389.1	MedGen:OMIM:Orphanet:SNOMED_CT|Human_Phenotype_Ontology:MedGen|Human_Phenotype_Ontology:MedGen	C0162568:177000:ORPHA79278:51022005|HP:0010783:C0041834|HP:0000952:C0022346																																																																		
chr20	4699605	4699605	A	G	exonic	PRNP		nonsynonymous SNV	PRNP:NM_000311:exon2:c.A385G:p.M129V,PRNP:NM_001080121:exon2:c.A385G:p.M129V,PRNP:NM_001080122:exon2:c.A385G:p.M129V,PRNP:NM_001080123:exon2:c.A385G:p.M129V,PRNP:NM_183079:exon2:c.A385G:p.M129V	rs1799990	other|other|other|Pathogenic|Pathogenic|Benign|Likely benign	Prion_disease,_susceptibility_to|Alzheimer_disease,_early-onset,_susceptibility_to|Aphasia,_primary_progressive,_susceptibility_to|Jakob-Creutzfeldt_disease|Fatal_familial_insomnia|Genetic_prion_diseases|not_specified	RCV000014331.7|RCV000014332.7|RCV000014333.7|RCV000014336.24|RCV000014337.24|RCV000020244.2|RCV000118064.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen	C0022336:123400:ORPHA204:792004|C0206042:600072:ORPHA466:83157008|C0162534|CN169374	0.024	0.496	D	0.009	0.251	B	0.012	0.225	B	0.002	0.385	N	0.184	0.347	P	1.01	0.254	L	-2.95	0.919	D	-0.66	0.202	N	0.68	0.688	-1.093	0.050	T	0.000	0.000	T	.	.	.	0.871	0.177	9.896	0.971	0.320	0.545	0.294	D	c	-0.252	-0.134	0.998	0.366	0.706	0.609	0	2.93	0.329	0.542	0.228	1.088	0.866	0.998	0.411	1.000	0.888	5.837	0.177	Prion/Doppel protein, beta-ribbon domain	ENSG00000171867.12|ENSG00000171867.12|ENSG00000171867.12|ENSG00000171867.12	Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Thyroid
chr21	45511195	45511195	G	A	exonic	COL18A1		nonsynonymous SNV	COL18A1:NM_030582:exon41:c.G4309A:p.D1437N,COL18A1:NM_130444:exon41:c.G5014A:p.D1672N,COL18A1:NM_130445:exon42:c.G3769A:p.D1257N	rs12483377	Pathogenic|Benign	Knobloch_syndrome_1|not_specified	RCV000018655.28|RCV000248578.1	MedGen:OMIM:Orphanet|MedGen	C1849409:267750:ORPHA1571|CN169374	0.057	0.388	T	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.000	0.810	P	2.395	0.694	M	0.6	0.537	T	-3.93	0.752	D	0.075	0.287	-0.935	0.434	T	0.018	0.076	T	.	.	.	5.958	0.818	27.7	0.999	0.973	0.853	0.441	D	c	0.552	0.487	1.000	0.517	0.672	0.522	0	5.04	0.672	6.538	0.736	1.036	0.656	1.000	0.715	0.595	0.288	16.245	0.822	C-type lectin fold|C-type lectin-like|Collagenase NC10/endostatin	.	.
chrX	154534556	154534556	G	C	intronic	G6PD				rs2515904	Pathogenic	Glucose_6_phosphate_dehydrogenase_deficiency	RCV000011095.5	MedGen	C0017758																																																																		
